Without FDA oversight of the compounding process, potency consistency is less guaranteed than with brand-name products
Proper technique ensures consistent absorption and predictable pharmacokinetics, which is essential for staying on schedule with the dosing protocol
The body composition substudy The Lancet Diabetes and Endocrinology published a substudy specifically examining body composition changes using DXA scanning, the gold standard for measuring fat versus lean mass
About half (54%) of those who report ever taking the drugs say it was difficult to afford them, including one in five (22%) who say it was very difficult. Having insurance coverage makes little difference to patients perceptions of the drugs affordability, with similar shares of those covered by insurance saying the drugs were difficult (53%) or very difficult (23%) to afford
Mochi Health's influencer-driven campaigns resonated with younger demographics searching for affordable alternatives to brand-name Wegovy and Ozempic, which can cost upwards of $1,300/month without insurance coverage
